Fragmentomics pioneer showcases DELFI-TF treatment monitoring solution alongside early detection capabilities at a premier oncology research event BALTIMORE and PALO ALTO, Calif., April 25, 2025 /PRNewswire/ — DELFI Diagnostics, Inc., developer of innovative blood-based tests that…
